10.1016/s1535-6108(03)00276-9
Crossref journal-article
Elsevier BV
Cancer Cell (78)
Bibliography

Moses, M. A., Brem, H., & Langer, R. (2003). Advancing the field of drug delivery. Cancer Cell, 4(5), 337–341.

Authors 3
  1. Marsha A Moses (first)
  2. Henry Brem (additional)
  3. Robert Langer (additional)
References 35 Referenced 294
  1. {'key': '10.1016/S1535-6108(03)00276-9_BIB1', 'series-title': 'Made to Measure', 'author': 'Ball', 'year': '1997'} / Made to Measure by Ball (1997)
  2. 10.1016/S0140-6736(95)90755-6 / Lancet / Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas by Brem (1995)
  3. {'key': '10.1016/S1535-6108(03)00276-9_BIB3', 'first-page': '2', 'article-title': 'Polymer-based drug delivery to the brain', 'volume': '3', 'author': 'Brem', 'year': '1996', 'journal-title': 'Sci. Med.'} / Sci. Med. / Polymer-based drug delivery to the brain by Brem (1996)
  4. {'key': '10.1016/S1535-6108(03)00276-9_BIB4', 'first-page': '1878', 'article-title': 'Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer', 'volume': '60', 'author': 'Browder', 'year': '2000', 'journal-title': 'Cancer Res.'} / Cancer Res. / Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer by Browder (2000)
  5. {'key': '10.1016/S1535-6108(03)00276-9_BIB5', 'first-page': '6831', 'article-title': 'Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors', 'volume': '62', 'author': 'Campbell', 'year': '2002', 'journal-title': 'Cancer Res.'} / Cancer Res. / Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors by Campbell (2002)
  6. 10.1016/0960-0760(90)90446-R / J Steroid Biochem. Mol. Biol. / A new extra long acting depot preparation of the LHRH analogue Zoladex®. First endocrinological and pharmacokinetic data in patients with advanced prostate cancer by Dijkmana (1990)
  7. 10.1038/nrd1088 / Nat. Rev. Drug Discov. / The dawning era of polymer therapeutics by Duncan (2003)
  8. 10.1097/00006123-199811000-00093 / Neurosurgery / Local delivery of chemotherapy prolongs survival in experimental brain metastases from breast cancer by Ewend (1998)
  9. 10.1074/jbc.M306176200 / J. Biol. Chem. / Structural and functional uncoupling of the enzymatic and angiogenic inhibitory activities of TIMP-2 by Fernandez (2003)
  10. 10.1056/NEJM199511023331807 / N. Engl. J. Med. / Drug therapy–Nicotine medications for smoking cessation by Henningfield (1995)
  11. 10.1146/annurev.bioeng.1.1.241 / Annu. Rev. Biomed. Eng. / Transport of molecules, particles, and cells in solid tumors by Jain (1999)
  12. 10.1038/nm0901-987 / Nat. Med. / Normalizing the tumor vasculature with anti-angiogenic therapy by Jain (2001)
  13. {'key': '10.1016/S1535-6108(03)00276-9_BIB13', 'first-page': '7669', 'article-title': 'Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model', 'volume': '61', 'author': 'Kisker', 'year': '2001', 'journal-title': 'Cancer Res.'} / Cancer Res. / Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model by Kisker (2001)
  14. 10.1172/JCI8829 / J. Clin. Invest. / Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity by Klement (2000)
  15. {'issue': 'Suppl', 'key': '10.1016/S1535-6108(03)00276-9_BIB15', 'first-page': '5', 'article-title': 'Drug delivery and targeting', 'volume': '392', 'author': 'Langer', 'year': '1998', 'journal-title': 'Nature'} / Nature / Drug delivery and targeting by Langer (1998)
  16. 10.1038/263797a0 / Nature / Polymers for the sustained release of proteins and other macromolecules by Langer (1976)
  17. 10.1126/science.935859 / Science / Isolation of a cartilage factor that inhibits tumor neovascularization by Langer (1976)
  18. 10.1227/01.NEU.0000073783.96617.3A / Neurosurgery / Gliadel for pituitary adenomas and craniopharyngiomas by Laws (2003)
  19. {'key': '10.1016/S1535-6108(03)00276-9_BIB19', 'first-page': '2731', 'article-title': 'Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water', 'volume': '62', 'author': 'Man', 'year': '2002', 'journal-title': 'Cancer Res.'} / Cancer Res. / Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water by Man (2002)
  20. McCarthy, S. (2003). Antiangiogenesis drug promising for metastatic colorectal cancer - New treatments for colorectal cancer might improve patients' survival, investigators reported at ASCO. Lancet 361, 1959. (10.1016/S0140-6736(03)13603-3)
  21. 10.1038/nbt0791-630 / Biotechnology / Inhibitors of angiogenesis by Moses (1991)
  22. 10.1073/pnas.96.6.2645 / Proc. Natl. Acad. Sci. USA / Troponin I is present in human cartilage and inhibits angiogenesis by Moses (1999)
  23. 10.1248/cpb.36.1095 / Chem. Pharm. Bull. / A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid and copoly(lactic/glycolic acid) by Ogawa (1988)
  24. 10.1016/S0169-409X(97)00050-1 / Adv. Drug Deliv. Rev. / One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate by Okada (1997)
  25. 10.1002/jps.2600711214 / J. Pharm. Sci. / Vaginal absorption of a potent luteinizing-hormone-releasing hormone analog (leuprolide) in rats-1-absorption by various routes and absorption enhancement by Okada (1982)
  26. 10.1016/0092-8674(94)90200-3 / Cell / Angiostatin by O'Reilly (1994)
  27. 10.1016/S0092-8674(00)81848-6 / Cell / Endostatin by O'Reilly (1997)
  28. 10.1126/science.8134835 / Science / New challenges in biomaterials by Peppas (1994)
  29. Prausnitz, M., Mitragotri, S., and Langer, R. (2003). Current status and future potential of transdermal drug delivery. Nature Drug Discovery, in press.
  30. {'key': '10.1016/S1535-6108(03)00276-9_BIB30', 'first-page': '709', 'article-title': 'Multi-pulse drug delivery from a resorbable polymeric microchip device', 'volume': '2', 'author': 'Richards-Grayson', 'year': '2003', 'journal-title': 'Nat. Mater.'} / Nat. Mater. / Multi-pulse drug delivery from a resorbable polymeric microchip device by Richards-Grayson (2003)
  31. 10.1038/16898 / Nature / A controlled-release microchip by Santini (1999)
  32. 10.1016/S0090-4295(03)00330-3 / Urology / An eight-month clinical study of LA-2575 30.0 mg by Sartor (2003)
  33. 10.1097/00006123-199707000-00011 / Neurosurgery / Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas by Valtonen (1997)
  34. 10.3171/jns.1995.82.4.0635 / J. Neurosurg. / The role of minocycline in the treatment of intracranial 9L glioma by Weingarten (1995)
  35. 10.1093/neuonc/5.2.79 / Neuro-oncol. / A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant gliomas by Westphal (2003)
Dates
Type When
Created 21 years, 4 months ago (April 14, 2004, 5:27 a.m.)
Deposited 6 years, 6 months ago (Feb. 13, 2019, 9:54 p.m.)
Indexed 3 days, 11 hours ago (Sept. 3, 2025, 6:31 a.m.)
Issued 21 years, 10 months ago (Nov. 1, 2003)
Published 21 years, 10 months ago (Nov. 1, 2003)
Published Print 21 years, 10 months ago (Nov. 1, 2003)
Funders 0

None

@article{Moses_2003, title={Advancing the field of drug delivery}, volume={4}, ISSN={1535-6108}, url={http://dx.doi.org/10.1016/s1535-6108(03)00276-9}, DOI={10.1016/s1535-6108(03)00276-9}, number={5}, journal={Cancer Cell}, publisher={Elsevier BV}, author={Moses, Marsha A and Brem, Henry and Langer, Robert}, year={2003}, month=nov, pages={337–341} }